Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcrip

Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28.

Related Keywords

United States , America , Varant Shirvanian , Michael Schmidt , Amy Peterson , Mike Morrissey , Peter Lamb , Chris Senner , Neeraj Agarwal , Christopher Senner , Dana Aftab , Michael Morrissey , Monty Pal , Jennifer Chan , Joe Catanzaro , Jason Gerberry , Laura Dillard , Cabo Atezo , Joseph Catanzaro , Broad Institute , Alliance For Clinical Trials In Oncology , Nasdaq , Exelixis Inc , Fastest Growing Fintech Companies , Exchange Commission , Call Transcript April , Exelixis First Quarter , Results Conference , Chief Financial Officer , Executive Vice President , Chief Medical Officer , Chief Scientific Officer , Risk Factors , Clinical Trials , Scientific Strategy , Human Resources , Highest Suicide Rates ,